Looking different, feeling different: Women's reactions to risk-reducing breast and ovarian surgery

Familial Cancer

Volumn 11, Issue 2, 2012, Pages 215-224

  Hallowell, Nina ^a   Baylock, Brandi ^b   Heiniger, Louise ^b   Butow, Phyllis N ^b   Patel, Deepa ^b   Meiser, Bettina ^c   Saunders, Christobel ^d   Price, Melanie A ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

BRCA1 and BRCA2; Breast and ovarian cancer; Qualitative; Risk reducing surgery; Sexuality and body image

Indexed keywords

ADULT; AGED; ARTICLE; BREAST RECONSTRUCTION; CANCER RISK; CLINICAL ARTICLE; EMOTION; FEMALE; HIGH RISK PATIENT; HUMAN; MASTECTOMY; MENOPAUSE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RISK REDUCING MASTECTOMY; RISK REDUCING SALPINGOOOPHORECTOMY; SALPINGOOOPHORECTOMY; SEMI STRUCTURED INTERVIEW; SENSATION; SEXUALITY;

ADULT; AGED; BODY IMAGE; BRCA1 PROTEIN; BRCA2 PROTEIN; COUNSELING; EMOTIONS; EXPRESSED EMOTION; FALLOPIAN TUBES; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MAMMAPLASTY; MASTECTOMY; MENOPAUSE; MIDDLE AGED; OVARIAN NEOPLASMS; OVARIECTOMY; PROSPECTIVE STUDIES;

EID: 84863874939     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-011-9504-4     Document Type: Article

References (43)

1. Ford D et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62(3):676-689
2. Risch HA et al (2006) Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: A kin-cohort study in Ontario, Canada. J Natl Cancer Inst 98(23):1694-1706
3. Metcalfe K et al (2010) Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations. J Natl Cancer Inst 102(24):1874-1878
4. Hartmann LC et al (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93(21):1633-1637
5. Meijers-Heijboer H et al (2003) Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. J Clin Oncol 21(9):1675-1681
6. Rebbeck TR et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: The PROSE study group. J Clin Oncol 22(6):1055-1062
7. Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-Analysis of risk reduction estimates associated with risk-reducing salpingooophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101(2):80-87
8. Evans DG et al (2009) Screening for familial ovarian cancer: Poor survival of BRCA1/2 related cancers. J Med Genet 46(9):593-597
9. Maribs Study Group (2005) Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer. Lancet 365 (9474): 1848-1848
10. Kriege M et al (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351(5):427-437
11. Evans DG et al (2009) Risk reducing mastectomy: Outcomes in 10 European centres. J Med Genet 46(4):254-258
12. Finch A et al (2006) Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation. J Am Med Assoc 296(2):185-192
13. Domchek SM et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. J Am Med Assoc 304(9):967-975
14. Kurian AW, Sigal BM, Plevritis SK (2010) Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers. J Clin Oncol 28(2):222-231
15. Nelson HD, Fu R, Griffin JC, Nygren P, Smith MEB, Humphrey L (2009) Systematic review: Comparative effectiveness of medications to reduce risk for primary breast cancer. Ann Intern Med 151(10):703-715
16. Brandberg Y et al (2008) Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: A prospective 1-year followup study. J Clin Oncol 26(24):3943-3949
17. Dowdy SC, Stefanek M, Hartmann LC (2004) Surgical risk reduction: Prophylactic salpingo-oophorectomy and prophylactic mastectomy. Am J Obstet Gynecol 191(4):1113-1123
18. Miller SM et al (2010) New strategies in ovarian cancer: Uptake and experience of women at high risk of ovarian cancer who are considering risk-reducing salpingo-oophorectomy. Clin Cancer Res 16(21):5094-5106
19. Borgen PI, Hill AD, Tran KN, Van Zee KJ, Massie MJ, Payne D, Biggs CG (1998) Patient regrets after bilateral prophylactic mastectomy. Ann Surg Oncol 5(7): 603-606
20. McGaughey A (2006) Body image after bilateral prophylactic mastectomy: An integrative literature review. J Midwifery Womens Health 51(6):e45-e49
21. Spear SLMD et al (2008) Prophylactic mastectomy and reconstruction: Clinical outcomes and patient satisfaction. Plast Reconstr Surg 122(1):1-9
22. Altschuler A et al (2008) Positive, negative, and disparate-women's differing long-Term psychosocial experiences of bilateral or contralateral prophylactic mastectomy. Breast J 14(1): 25-32
23. Bebbington Hatcher M, Fallowfield LJ (2003) A qualitative study looking at the psychosocial implications of bilateral prophylactic mastectomy. Breast 12(1):1-9
24. Bresser PJC et al (2006) Satisfaction with prophylactic mastectomy and breast reconstruction in genetically predisposed women. Plast Reconstr Surg 117(6):1675-1682
25. Lodder LN et al (2002) One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: Emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery). Breast Cancer Res Treat 73(2):97-112
26. Frost MH et al (2000) Long-Term satisfaction and psychological and social function following bilateral prophylactic mastectomy. J Am Med Assoc 284(3):319-324
27. Hallowell N (2000) A qualitative study of the information needs of high-risk women undergoing prophylactic oophorectomy. Psychooncology 9(6):486-495
28. Hallowell N, Lawton J (2002) Negotiating present and future selves: Managing the risk of hereditary ovarian cancer by prophylactic surgery. Health Interdiscip J Soc Study Health Illn Med 6(4):423-443
29. Bonadies DC, Moyer A, Matloff ET (2011) What I wish I'd known before surgery: BRCA carriers' perspectives after bilateral salipingo-oophorectomy. Fam Cancer 10(1):79-85
30. Bresser PJC et al (2007) The course of distress in women at increased risk of breast and ovarian cancer due to an identified genetic susceptibility who opt for prophylactic mastectomy and/ or salpingo-oophorectomy. Eur J Cancer 43(1):95-103
31. Geiger AMP et al (2007) Quality of life after bilateral prophylactic mastectomy. Ann Surg Oncol 14(2):686-694
32. Rolnick SJ et al (2007) What women wish they knew before prophylactic mastectomy. Cancer Nurs 30(4):285-293
33. Mann GJ et al (2006) Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 8(1): R12 Epub
34. Phillips K-A, Butow P, Stewart A, Chang J-H, Weideman P, Price M et al (2005) Predictors of participation in clinical and psychosocial follow up of the kConFab breast cancer family study. Fam Cancer 4:105-113
35. Corbin J, Strauss A (1990) Grounded theory research-procedures, canons and evaluative criteria. Z Soziol 19(6):418-427
36. van Oostrom I et al (2003) Long-Term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: A 5-year follow-up study. J Clin Oncol 21(20):3867-3874
37. Finch A et al (2011) The impact of prophylactic salpingooophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation. Gynecol Oncol 121(1): 163-168
38. National Health Medical Research Council of Australia (1999) Guidelines on familial aspects of cancer. Canberra, Australian Cancer Network
39. Hallowell N et al (2004) High-risk premenopausal women's experiences of undergoing prophylactic oophorectomy: A descriptive study. Genet Test 8(2):148-156
40. Information for Women Considering Prophylactic Removal of the Breast in BRCAs Risk Reducing Mastectomy (2009) Familial Cancer Unit, SA Clinical Genetics Service, SA Pathology, Adelaide SA 5000
41. Rocca WA, Bower JH, Maraganore DM, Ahlskog JE, Grossardt BR, de Andrade M, Melton LJ 3rd (2007) Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurol 69:1074-1083
42. Challberg J et al (2011) Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: Significant bone health issues in those not taking HRT. Br J Cancer 105(1):22-27
43. Hickey M, Emery LI, Gregson J, Doherty DA, Saunders CM (2010) The multidisciplinary management of menopausal symptoms after breast cancer: A unique model of care. Menopause J North Am Menopause Soc 17(4):727-733